Catawba Capital Management’s Boston Scientific BSX Stock Holding History

Catawba Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$203K	Buy	+6,200	New	+$187K	0.05%	204
2017 Q3	–	Sell	-32,505	Closed	-$901K	–	223
2017 Q2	$901K	Buy	32,505 +525	+2%	+$13.9K	0.21%	101
2017 Q1	$795K	Hold	31,980	–	–	0.17%	119
2016 Q4	$692K	Buy	31,980 +3,690	+13%	+$80.5K	0.16%	129
2016 Q3	$673K	Hold	28,290	–	–	0.16%	129
2016 Q2	$661K	Sell	28,290 -1,200	-4%	-$26K	0.16%	126
2016 Q1	$555K	Buy	29,490 +680	+2%	+$11.9K	0.14%	131
2015 Q4	$531K	Buy	28,810 +4,345	+18%	+$77.9K	0.14%	126
2015 Q3	$401K	Buy	24,465 +1,200	+5%	+$20.5K	0.11%	154
2015 Q2	$412K	Hold	23,265	–	–	0.1%	162
2015 Q1	$413K	Buy	+23,265	New	+$368K	0.09%	168

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Catawba Capital Management's BSX Position: Q2 2018 in Review

Catawba Capital Management opened a new position in Boston Scientific (BSX) in Q2 2018: 6,200 shares worth $203K. The stake represents 0.05% of the portfolio and ranks #204 among its holdings. This is a return to the name: Catawba Capital Management previously reported a position in BSX as recently as Q2 2017.

Catawba Capital Management first reported a position in BSX in Q1 2015 and has held it in 11 quarters since. The position peaked at $901K in Q2 2017. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

Catawba Capital Management held 6,200 shares of Boston Scientific worth $203K as of Q2 2018.
Boston Scientific was a new Catawba Capital Management position in Q2 2018.
Boston Scientific made up 0.05% of Catawba Capital Management's portfolio in Q2 2018, its #204 holding.
Catawba Capital Management first reported a position in Boston Scientific in Q1 2015 and has held it in 11 quarters since.
Catawba Capital Management's Boston Scientific position peaked at $901K in Q2 2017.
671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.